Price
239.95
+1.05%52W Range
Market Cap
₹2,346.06 Cr
Traded: ₹0.00 Cr (0.00%) 0.0x
Free Float: ₹99.94 Cr (0.00% of FF traded)
Volume · 60D trend
47 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | +13.0% | -- | -- | -- |
| Sales | -- | -- | -- | -- | +192.0% | -- |
| Profit | -- | -- | +441.0% | -- | -43.0% | Decelerating |
| Return | -- | +98.0% | +98.0% | +127.0% | -- | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258 | 261 | 192 | 216 | 203 | 214 | 85 | 0 | 0 | 7 | 0 | 0 | 0 | 0 |
| Expenses | 252 | 257 | 208 | 215 | 180 | 255 | 77 | 4 | 1 | 8 | 1 | 1 | 0 | 0 |
| Operating Profit | 6 | 4 | -16 | 1 | 24 | -41 | 8 | -4 | -1 | -1 | -1 | -1 | -0 | -0 |
| OPM % | 2.3% | 1.6% | -8.4% | 0.6% | 11.7% | -18.9% | 9.2% | -- | -- | -12.7% | -- | -- | -- | -- |
| Other Income | 0 | 0 | 9 | 0 | 0 | 61 | 6 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Interest | 1 | 1 | 0 | 1 | 0 | 2 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | 4 | -8 | 1 | 23 | 19 | 11 | -6 | -2 | -1 | -1 | -1 | -0 | -0 |
| Tax % | 43.0% | 24.2% | -15.9% | -3043.9% | 13.4% | -0.4% | 9.3% | -11.2% | -13.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 3 | 3 | -7 | 18 | 20 | 19 | 10 | -6 | -2 | -1 | -1 | -1 | -0 | -0 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| EPS (Rs) | 0.3 | 0.3 | -0.7 | 1.8 | 2.0 | 2.0 | 9.6 | -5.8 | -1.9 | -0.9 | -1.3 | -0.6 | -0.3 | -0.1 |
| Sales Growth (YoY) | 26.7% | 22.0% | 125.4% | -- | -- | 2921.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | 36.0% | -11.3% | 6.5% | -5.1% | 151.3% | -- | -- | -100.0% | -- | -- | -- | -- | -- |
| OP Growth (YoY) | -75.2% | 110.4% | -306.5% | 136.5% | 2325.2% | -4405.6% | 720.6% | -475.4% | -256.7% | -1185.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | 40.0% | 126.1% | -1361.7% | -94.6% | 158.7% | -618.5% | 322.8% | -228.0% | -18.9% | 28.6% | -106.6% | -103.3% | -328.6% | -- |
| Profit Growth (YoY) | -85.0% | -85.0% | -167.0% | 415.0% | 1146.0% | 2215.0% | 901.0% | -833.0% | -540.0% | -911.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -84.8% | -107.2% | 131.8% | 205.7% | 314.1% | 856.7% | -827.4% | -470.6% | -922.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 143.5% | -137.7% | -10.7% | 4.1% | -79.5% | 267.1% | -196.4% | -110.9% | 27.6% | -104.8% | -82.3% | -277.8% | -- |
| OP Margin | -- | 1.6% | -8.4% | 0.6% | 11.7% | -18.9% | 9.2% | -- | -- | -12.7% | -- | -- | -- | -- |
| Net Margin | -- | 1.1% | -3.5% | 8.3% | 9.9% | 9.0% | 11.8% | -- | -- | -12.8% | -- | -- | -- | -- |
| Material Cost % | 97.0% | 88.0% | 106.0% | 85.0% | 87.0% | 96.0% | 88.0% | -- | -- | 98.0% | -- | -- | -- | -- |
| Employee Cost % | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 0.0% | 0.0% | -- | -- | 9.0% | -- | -- | -- | -- |
| P/S | 2.53 | 2.86 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 137.90 | 73.14 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.02 | 5.34 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Pursuant to Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find attached herewith publication of first quarter ....
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the meeting updates for Board Meeting held today i.e. ....
The Board of Directors in their meeting held today considered and approved the financial results (Standalone & Consolidated ) for the quarter ended June 30, 2026.
Outcome of Board Meeting inter-alia to consider and approve Un-audited Standalone and Consolidated financial results for the first quarter ended June 30, 2026.
BN Agrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated ....
Pursuant to Regulation 74(5) of SEBI (Depository and Participant) Regulations 2018, please find attached herewith the certificate issued by RTA confirming the dematerialisation of share certificates.
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, please find attached herewith the Intimation of Insider Trading window closure for the first quarter ended June 30, 2026.
Pursuant to Regulation 30 as per SEBI (LODR) Regulation, 2015 please find attached an update on scheme of amalgamation.
Pursuant to Regulation 30 read with regulation 47 of SEBI LODR 2015, please find attached herewith the intimation of newspaper publication.
Pursuant Regulation 24 A of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, please find attached Annual Secretarial Compliance Report for the year ended March 31, 2026.
The Board of directors in their meeting held today considered and approved the financial results (Standalone and Consolidated) for the year ended March 31, 2026.
Pursuant to Regulation 30 of SEBI LODR 2015, please find attached decisions taken by Board of Directors in their meeting held today.
Outcome of Board Meeting inter-alia to consider and approve Audited Standalone and Consolidated financial results for fourth quarter and year ended March 31, 2026.
BN Agrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated ....
Pursuant to Regulation 30 of SEBI (LODR), 2015 and in furtherance to announcement dated June 28, 2025, December 17, 2025 and March 05, 2026, please find attached copy of the approval received ....
Pursuant to Regulation 74(5) of SEBI (Depository and Participant) Regulations 2018, please find attached herewith the certificate issued by RTA confirming the dematerialisation of share certificates
Pursuant to SEBI (Prohibition of Insider Trading)Regulations, 2015, please find attached herewith the Intimation of Insider Trading Window Closure for the fourth quarter and financial year ....
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)Regulations, 2015, please find attached an update on Scheme of Amalgamation filed by the Company.
Pursuant to Regulation 30 of SEBI (LODR), 2015, please find attached herewith intimation of publication of financial results for the third quarter and nine months ended December 31, 2025 in newspaper.
Pursuant to Regulation 30 read with regulation 33 of SEBI (LODR) 2015, please find attached un-audited Standalone & Consolidated for the third quarter ended December 31, 2025.
Please find attached the announcement under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting inter-alia to consider and approve un-audited Standalone and Consolidated financial results for third quarter and nine months ended December 31, 2025.
BN Agrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial results (Standalone ....
Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, please find attached herewith the certificate issued by RTA confirming the dematerialisation of share certificates.
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, please find attached herewith the intimation for Trading Window Closure for the third quarter ended December 31, 2025.
This is in furtherance to our intimation dated June 28, 2025 wherein the Board of Directors ('Board') of BN Agrochem Limited ('Company' or 'Transferee Company') had approved the Scheme ....
Pursuant to Regulation 30 read with Regulation 33 of SEBI (LODR), 2015, please find attached herewith the un-audited standalone and consolidated financial results for the second quarter ....
Outcome of Board Meeting inter-alia to consider and approve un-audited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2025.
Please find attached announcement under Regulation 30 of SEBI LODR , 2015.
BN Agrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited financial results (Standalone ....
Please find attached an update from Company on announcement dated September 06, 2025.
Please find attached update from company on Announcement dated September 06, 2025.
Pursuant to Regulation 30 read with Schedule III of SEBI(Listing Obligation and Disclosure Requirements)Regulations, 2015, please find attached announcement from Company.
Pursuant to Regulation 74(5) of SEBI (DP ) Regulations, 2018, please find attached herewith the certificate from RTA of the Company for the quarter ended September 30, 2025
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in furtherance to announcement dated July 23, 2025, please find attached herewith ....
In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the proceedings of 34th ....
Pursuant to Regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached the Scrutinizer Report along with the voting results for the remote ....
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the update from the company.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the intimation of Newspaper publication.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find attached herewith the Notice of convening 34th Annual General Meeting of the Company.
Pursuant to Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the intimation of Newspaper Advertisement.
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached here with the announcement from company ....
Pursuant to Regulation 30 of SEBI(Listing Obligation and Disclosure Requirement) Regulations, 2015, please find attached herewith the announcement from Company.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find an update from company.
Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find attached herewith the Scrutinizer''s Report along with voting results for ....
In compliance with Regulation 30 read with Schedule III and other applicable provisions of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find attached ....
Pursuant to Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find attached herewith the intimation of publication ....
Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Un-audited Standalone and Consolidated Financial ....
Outcome of Board Meeting inter -alia to consider and approve the Un-audited Standalone and Consolidated financial results for the first quarter ended June 30, 2025.
BN Holdings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....